Scott Myers

Scott Myers

Former President, Chief Executive Officer and DirectoratViridian Therapeutics, Inc.\DE· In the 2023 proxy

Pay in FY2023Viridian Therapeutics, Inc.\DE stock -25.4% the same year

Scott Myers was paid $36.4M in FY2023 (Dec). Viridian Therapeutics, Inc.\DE stock fell 25.4% that year.

Pay$100 in the stock at the end of FY22 → $75
Pay is from the Summary Compensation Table of each Viridian Therapeutics, Inc.\DE proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Viridian Therapeutics, Inc.\DEPublic company · 3 yr
    • Former President, Chief Executive Officer and Director2023 – Present · 3 yrStock in role -15%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?